Overview

A Study of GSK1325760A in Healthy Japanese Subjects

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
To investigate the safety, tolerability, pharmacokinetics and the effect of food on pharmacokinetics after single oral administrations of GSK1325760A
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline